Centrexion Therapeutics Corporation announced that it will receive $13,500,000 in funding on January 12, 2021. The company will issue convertible debt in the transaction. The company will issue securities pursuant to exemption provided under Regulation D. The company has paid $945,000 in case and plus the issuance of a warrant to purchase 96,076 shares of common stock to Maxim Group LLC.